Related content

RUCAM in Drug and Herb Induced Liver Injury: The Update

By Danan Gaby   Teschke Rolf  

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2015-12 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury

By McEuen Kristin   Borlak Jürgen   Tong Weida   Chen Minjun  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1335-1335

MDPI

Access to resources Recommend Favorite

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury

By Ortega-Alonso Aida   Stephens Camilla   Lucena M. Isabel   Andrade Raúl J.  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 714-714

MDPI

Access to resources Recommend Favorite

Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?

By Teschke Rolf   Schulze Johannes   Eickhoff Axel   Danan Gaby  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 803-803

MDPI

Access to resources Recommend Favorite

Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States

By Hayashi Paul H.  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 201-201

MDPI

Access to resources Recommend Favorite